Thursday, 15 June 2017
Dublin Hosts AQC Euro Summit
The annual Avoca Quality Consortium (AQC) European Summit, which recently took place in Dublin, hosted a wide range of speakers and discussion forms to debate how the Irish clinical trial industry could advance with best practice in a changing landscape.
Ms. Patricia Leuchten, CEO of The Avoca Group and Founder of the AQC, opened the conference with a welcome address highlighting the changing landscapes of clinical trials across Ireland and Europe. This was supported by the Consortium’s new ‘Regulatory Roadmap’ which is a set of practical guidelines, tools, and documents, recently released by the group, to empower AQC members to understand the newly rolled out ICH E6 R2 (regulatory guidelines on drug development) which go into effect in Europe on June 14th, 2017.
“We are delighted to host our European Summit in Dublin this year and really want to thank all our Irish and international members for attending the summit. Ireland is an innovative and exciting environment, with an impressive life science footprint and strong capabilities in research and development, which was demonstrated by our key note speaker Prof. Mark Ferguson”.
“The AQC’s focus is on supporting our members and the work they do by providing them with leading practices and information that will help them drive efficiency and identify and mitigate risks in clinical trial execution. For example, Avoca began our work on the components of ICH E6 R2 five years ago, and as a result, we are now well placed to support the industry when the new regulatory guidelines are released in Europe next week."
Prof. Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government, spoke about how Ireland ranked 10th place (2016) for the overall quality of scientific research.
“I was delighted to be asked to speak at the AQC European Summit and very pleased to be able to welcome the Summit here to Dublin. Events such as this are extremely important and I must commend the initiative of The Avoca Group for providing industry with the opportunity to collaborate and engage in such an open manner”.
“Collaboration is extremely important and is something the Science Foundation Ireland are very in tune with; we have over 2,081 international scientific research collaborations in 62 countries, an additional 1,220 collaborations with industry, including 372 multinational cooperation’s and 437small and medium-sized enterprises. Ireland is also the most efficient research and development country in the EU as we extract the top percentile of innovation output from a below average public expenditure on our research and development.”
The European Summit's primary sponsor was ICON, the global CRO that has headquarters in Dublin. Also sponsoring the Summit were inVentiv Health, Purdue Pharma, Longboat, Bioclinica, Appian, and MedAvante.